Pseudohypoaldosteronism type 2D

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:300525OMIM:614495I15.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pseudohypoaldosteronism type 2D (PHA2D), also known as Gordon syndrome type D or familial hyperkalemic hypertension type D, is a rare genetic condition that affects how your kidneys handle salt and potassium. In this disease, the kidneys hold on to too much sodium (salt) and potassium instead of properly filtering them out. This leads to high blood pressure (hypertension) and high potassium levels in the blood (hyperkalemia), which can be dangerous if untreated. The condition is caused by mutations in the KLHL3 gene, which plays an important role in regulating a kidney salt transporter called NCC (sodium-chloride cotransporter). When this gene does not work properly, the NCC transporter becomes overactive, causing the kidneys to reabsorb too much salt and water. People with PHA2D may develop high blood pressure at a relatively young age, sometimes even in childhood or adolescence. Other common findings include high potassium levels, metabolic acidosis (too much acid in the blood), and sometimes low renin levels. The good news is that this condition often responds very well to treatment with thiazide diuretics, a type of water pill that directly blocks the overactive NCC transporter. With proper treatment, blood pressure and potassium levels can usually be brought under control, and patients can lead relatively normal lives. Early diagnosis and treatment are important to prevent long-term complications of high blood pressure, such as heart disease, stroke, and kidney damage.

Also known as:

Key symptoms:

High blood pressure, sometimes at a young ageHigh potassium levels in the bloodMetabolic acidosis (too much acid in the blood)Muscle weakness or crampingFatigue or tirednessHeart rhythm problems from high potassiumLow renin levels on blood testsNormal or low aldosterone levelsHeadaches from high blood pressureNumbness or tingling sensationsNausea or feeling unwell

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pseudohypoaldosteronism type 2D.

View clinical trials →

No actively recruiting trials found for Pseudohypoaldosteronism type 2D at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pseudohypoaldosteronism type 2D community →

No specialists are currently listed for Pseudohypoaldosteronism type 2D.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pseudohypoaldosteronism type 2D.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pseudohypoaldosteronism type 2DForum →

No community posts yet. Be the first to share your experience with Pseudohypoaldosteronism type 2D.

Start the conversation →

Latest news about Pseudohypoaldosteronism type 2D

No recent news articles for Pseudohypoaldosteronism type 2D.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of thiazide diuretic is best for me or my child, and what dose should we start with?,How often should blood pressure and blood potassium levels be checked?,Are there specific foods I should avoid or limit because of high potassium?,Should my family members be tested for this genetic condition?,What are the warning signs that potassium levels are dangerously high?,Will I need to take medication for the rest of my life?,Are there any medications I should avoid that could make my condition worse?

Common questions about Pseudohypoaldosteronism type 2D

What is Pseudohypoaldosteronism type 2D?

Pseudohypoaldosteronism type 2D (PHA2D), also known as Gordon syndrome type D or familial hyperkalemic hypertension type D, is a rare genetic condition that affects how your kidneys handle salt and potassium. In this disease, the kidneys hold on to too much sodium (salt) and potassium instead of properly filtering them out. This leads to high blood pressure (hypertension) and high potassium levels in the blood (hyperkalemia), which can be dangerous if untreated. The condition is caused by mutations in the KLHL3 gene, which plays an important role in regulating a kidney salt transporter called